Eledon Pharmaceuticals Statistics

Total Valuation

ELDN has a market cap or net worth of $260.46 million. The enterprise value is $182.77 million.

Market Cap	260.46M
Enterprise Value	182.77M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ELDN has 59.74 million shares outstanding. The number of shares has increased by 86.63% in one year.

Current Share Class	59.74M
Shares Outstanding	59.74M
Shares Change (YoY)	+86.63%
Shares Change (QoQ)	+30.86%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	20.50%
Float	46.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.36
P/TBV Ratio	5.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.53, with a Debt / Equity ratio of 0.01.

Current Ratio	6.53
Quick Ratio	6.26
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.89% and return on invested capital (ROIC) is -41.74%.

Return on Equity (ROE)	-25.89%
Return on Assets (ROA)	-33.36%
Return on Capital (ROIC)	-41.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +188.74% in the last 52 weeks. The beta is 0.76, so ELDN's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+188.74%
50-Day Moving Average	4.12
200-Day Moving Average	2.88
Relative Strength Index (RSI)	50.51
Average Volume (20 Days)	553,174

Short Selling Information

The latest short interest is 686,688, so 1.15% of the outstanding shares have been sold short.

Short Interest	686,688
Short Previous Month	731,494
Short % of Shares Out	1.15%
Short % of Float	1.48%
Short Ratio (days to cover)	0.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.22M
Pretax Income	-39.85M
Net Income	-24.55M
EBITDA	n/a
EBIT	-56.22M
Earnings Per Share (EPS)	-$2.36

Full Income Statement

Balance Sheet

The company has $78.19 million in cash and $501,000 in debt, giving a net cash position of $77.69 million or $1.30 per share.

Cash & Cash Equivalents	78.19M
Total Debt	501,000
Net Cash	77.69M
Net Cash Per Share	$1.30
Equity (Book Value)	76.06M
Book Value Per Share	1.85
Working Capital	69.02M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-37.42M
Capital Expenditures	n/a
Free Cash Flow	-37.42M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.63%
Shareholder Yield	-86.63%
Earnings Yield	-9.42%
FCF Yield	-14.36%

Analyst Forecast

The average price target for ELDN is $16.00, which is 266.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	266.97%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-36.30%

Stock Forecasts

Stock Splits

The last stock split was on October 5, 2020. It was a reverse split with a ratio of 0.0555555:1.

Last Split Date	Oct 5, 2020
Split Type	Reverse
Split Ratio	0.0555555:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a